This chapter should be cited as follows: This chapter was last updated:
Kulp, J, De Jonge, C, et al, Glob. libr. women's med.,
(ISSN: 1756-2228) 2009; DOI 10.3843/GLOWM.10317
March 2009


Egg Transport and Fertilization

Jennifer L. Kulp, MD
Clinical Instructor, Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University, New Haven, Connecticut, USA
Christopher J. De Jonge, PhD, HCLD
Professor, Department of Obstetrics and Gynecology; Director, Reproductive Medicine Center Laboratories, University of Minnesota, Minneapolis, Minnesota, USA
Pasquale Patrizio, MD, MBE, HCLD
Professor Obstetrics and Gynecology, Director Yale Fertility Center and REI Medical Practice, New Haven, Connecticut, USA


The process of fertilization is a complex sequence of events that starts with the release of a mature egg from the follicle, continues with the appearance of the two pronuclei after sperm entry, and is completed with the first mitotic divisions. In humans the uncovering of its complexities has been limited in a large part because of ethical constraints. However, with the advent of assisted reproductive technologies (ARTs), understanding of the various mechanisms involved in successful fertilization has been greatly enhanced. As ART has developed, so has the understanding of the essentials for human reproductive success. Still, a great deal more is known about reproductive processes in nonhuman mammals. This chapter focuses on what is currently known about human egg transport and fertilization.



Historically “egg transport” has referred to the movement of the oocyte, over time, from the moment of expulsion from the ovarian follicle to entry and travel into the distal segments of the fallopian tube (fimbrial and ampullary portion), before fertilization takes place. Once fertilized in the ampullary segment of the fallopian tube, the now called embryo, spends about 5 days traveling into the remaining anatomical oviductal districts and arrives into the uterine cavity at the blastocyst stage. For purposes of clarity and accuracy, the term egg transport covers postovulation and prefertilization stages (i.e., the haploid life span of the ovulated oocyte). A subsequent section provides details concerning transport of the fertilized (diploid) oocyte (i.e., zygote) and preimplantation embryo.

Before discussing the passage of the oocyte into and through the fallopian tube (oviduct), it is essential to briefly describe the anatomy and physiology of that structure. The fallopian tube is a muscular tube with an overall length on average of about 11–12 cm and is composed of four regions. The most distal portion is referred to as the infundibulum; it is approximately 1 cm in length and contains the finger-like fimbria. The epithelial lining of the fimbria is densely ciliated and highly convoluted. The former quality, along with the muscle-controlled movements of the fimbria, is thought to be important for capture of the cumulus-oocyte complex. The next portion of the oviduct is called the ampulla. This segment averages 5–8 cm in length. It is within this highly ciliated portion of the oviduct that fertilization and early embryo development occur. The ampulla is most often also the site for ectopic implantation. The next region, approximately 2–3 cm in length, is the isthmus. Like the ampulla, it too is ciliated yet less densely so. The isthmus is thought to regulate sperm and embryo transport. The last segment of the fallopian tube is called the intramural segment; it is the link between the isthmus of the oviduct and uterine cavity.1

The ciliated and nonciliated cells of the fallopian tube undergo cyclic changes with the menstrual cycle similar to those occurring in the endometrium. Further, each portion of the fallopian tube appears to be preferentially regulated by hormones that cause a distinct regionalization of activities, depending on the day in the female reproductive cycle.2 For example, in the follicular phase (day 4), propulsive forces operate throughout the length of the fallopian tube in the direction of the uterus. However, as the menstrual cycle continues, there are differences in regional activity of the fallopian tube. At day 8, the ampulla has alternating propulsive forces towards and away from the uterus. At the time of ovulation, ipsilateral transport to the ovary increases with increasing follicular diameter.3 It has been observed that pregnancy rates after intercourse are higher in those women who demonstrate ipsilateral transport, as opposed to those who fail to show lateralization. Therefore, it would appear that fallopian tube function is critical for the early stages of fertilization.

At the time of ovulation, the oocyte is surrounded by a mass of specialized granulosa cells termed the cumulus oophorus, and collectively called the cumulus-oocyte complex (COC). The several innermost cell layers of the cumulus (i.e., those immediately overlying the zona pellucida of the oocyte) are called the coronal cells. (After cumulus maturation the same cells are called the corona radiata because of their “sunburst” appearance.) These cells have processes that extend through the acellular glycoprotein matrix (i.e., the zona) to contact the oocyte plasma membrane for metabolic exchange (e.g., nutrients). The cumulus of the mature COC is rather sticky, and it is thought that this attribute facilitates the adherence of the COC to the surface of the ovary.

The mechanism by which the COC is picked up and gains entry into the fallopian tube lumen is uncertain. One possibility is that the fimbriated end of the ipsilateral fallopian tube sweeps over the ovary, picks up the COC, and draws it into the tubular lumen by muscular control. Paradoxically, women have become pregnant who were missing the fallopian tube on the side where ovulation occurred. Also, oocytes placed in the peritoneal cavity have been picked up by the fallopian tube and resulted in intrauterine pregnancies.4 This evidence implies that other forces are in place to facilitate oocyte pickup. Another possibility is that the rhythmic and unidirectional beating of cilia on the fimbriae – where the cilia have adhesive sites – and in the ampullary and isthmic regions of the fallopian tube, draw the COC into the lumen of the oviduct. However, this cannot be the sole mechanism by which the COC is picked up and transported through the fallopian tube, because women with immotile cilia syndrome (Kartagener's syndrome) are often fertile. Another possibility is that negative pressure results from muscular contractions of the oviduct, and the COC is aspirated from the surface of the ovary and into the lumen. However, capping and suturing of the fimbriated end in women has failed to prevent pregnancy.5 More recently, researchers, using sophisticated measuring techniques, reported that the uterus and fallopian tube appear to act as a peristaltic pump. The pumping frequency increases on the ipsilateral side, in the direction where ovulation will occur, and as the follicular diameter increases.3 A novel alternative to the aforementioned mechanisms for COC pickup is one involving mucus strand connections between fimbria and ovary that act as a tether between the two structures to facilitate fimbrial capture of the COC.5 The entire process of pickup and deposition of the COC into the lumen takes between 2 and 3 minutes after ovulation. Therefore, it would seem that at least several mechanisms are involved with COC pickup, the most important of which are ciliary beating, sweeping of the ovarian surface by the fimbria, and peristaltic pumping of the female tract.


After ovulation, the fertilizable life span of the mature human oocyte is estimated to be about 24 hours. In contrast, the fertilizable life span of the human spermatozoon is around 72 hours. Sperm motility can persist for much longer (and has been documented in vivo for up to 5 days), but fertilizing ability is lost before motility. Sperm deposited in the proximal vagina can be found in the fallopian tube within 5 minutes.6

In addition to the female factors described herein and in other chapters, certain male factors must be present for successful fertilization. The first factor is that a sufficient number of mature, viable spermatozoa must be present in the ejaculate. Second, the morphology of the sperm must be such that the cervical mucus will allow passage into the uterus. Third, it is essential that a good percentage of the sperm have forwardly progressive motion to propel them through the cervical mucus, into the uterine cavity and the fallopian tube for ultimate encounter with the COC. Fourth, at some time during sperm transport, and presumably close to the time of acrosome reaction and zona penetration, sperm motion should change to a hyperactivated state.7, 8

It is not until ejaculated spermatozoa are removed from seminal plasma and the process of capacitation has been initiated that sperm gain the ability to fertilize an oocyte. The term capacitation derives from the observation that sperm must spend time in the female reproductive tract in order to acquire the capacity or ability to fertilize an oocyte. Sperm can also undergo capacitation in vitro when they are incubated in media containing bovine serum albumin as well as energy substrates and electrolytes. Capacitation begins as sperm swim through the cervical mucus. Proteins adsorbed to the plasma membrane are removed and sperm surface molecules are modified. An efflux of cholesterol from the sperm plasma membrane may be the initiating event for capacitation. The sperm plasma membrane and outer acrosomal membrane have increased permeability and fluidity as a result of these changes. The more permeable sperm plasma membrane allows for influx of calcium and bicarbonate resulting in activation of second messengers and initiation of signaling events. These unique changes that prepare the spermatozoon for fertilization have collectively been termed capacitation, and were first described by Chang and Austin.9, 10

Some events that occur to induce capacitation are (1) an increase in membrane fluidity;8 (2) a decrease in net surface charge;8 (3) an increase in oxidative processes and cyclic adenosine monophosphate (cAMP) production;8, 11, 12 (4) a decrease in the ratio of plasma membrane cholesterol to phospholipid;8, 13, 14 (5) expression of mannose binding sites as a consequence of cholesterol removal;14 (6) an increase in tyrosine phosphorylation;11, 12 (7) an increase in reactive oxygen species;12 and (8) changes in sperm swimming patterns, termed hyperactivation.8, 15 The hyperactive beat of the sperm flagellum is believed to aid the sperm in traversing the cumulus cell complex and in binding to the zona pellucida. Successful capacitation of the sperm results in a hyperactivated spermatozoon which is able to bind to the zona pellucida and is susceptible to acrosome reaction induction.

The acrosome reaction is an exocytotic process occurring in the sperm head that is essential for penetration of the zona pellucida. Sperm that have not undergone an acrosome reaction, on or in extremely close proximity to the zona pellucida, cannot fertilize the oocyte without assistance. The acrosome is a unique organelle, located in the anterior portion of the sperm head analogous to both a lysosome and a regulated secretory vesicle.16, 17 One of the principal enzymes is a serine glycoproteinase called acrosin. It exists in a proenzyme form called proacrosin16 which is converted to acrosin (active form), perhaps by changes in acrosomal pH.

When sperm bind to the ZP, intracellular calcium is low. The binding causes an opening of calcium channels and an influx of calcium and second messengers that result in the acrosome reaction. Other substances may also induce the acrosome reaction. For example, the addition of periovulatory follicular fluid or progesterone to capacitated spermatozoa stimulates an influx of calcium ions that is coincident with the acrosome reaction.18, 19, 20, 21, 22 Because periovulatory follicular fluid contains progesterone, it is reasoned that this is the mechanism by which follicular fluid stimulates calcium influx and the acrosome reaction. Progesterone may be a secondary or co-inducer of the acrosome reaction. However, other acrosome reaction-stimulating factors (e.g., atrial natriuretic peptide) have also been detected in this complex fluid, and their role in fertilization cannot be discounted.23

A species-selective barrier to fertilization surrounding the mammalian oocyte is the zona pellucida, an acellular matrix consisting of four glycoproteins: ZP1, ZP2, ZP3, and ZP4. Experiments have shown that the zona pellucida is responsible for the initiation of sperm-zona binding, species-specific sperm-egg recognition, the acrosome reaction, and prevention of polysperm.24, 25, 26, 27 Using recombinant technology, the role of ZP3 in the fertilization process has been clarified. Specifically, ZP3 is the primary ligand for sperm-zona binding and acrosome reaction induction.28, 29 A more recently characterized glycoprotein, ZP4, also induces the acrosome reaction. ZP4, as opposed to ZP3, uses a G-protein independent signaling pathway to induce the acrosome reaction, but does share some common downstream signaling pathways with ZP3.30, 31, 32

Although ZP3 has been fairly well characterized as a ligand for sperm, such is not the case for ZP3 receptors on the sperm plasma membrane. The majority of current data concerning sperm receptors for zona glycoproteins is restricted to nonhuman mammalian and nonmammalian species. In the human, one of the best described ZP3 receptor candidates is a lectin that binds mannose-containing ligands.14 Another ZP3 receptor candidate on human sperm is a 95-kd receptor tyrosine kinase (RTK).33 This receptor is thought to initiate intracellular pH changes that culminate in the acrosome reaction. Interestingly, not only does intact zona pellucida stimulate tyrosine phosphorylation but so also does progesterone.34 Whether these two agonists act via the same RTK is questionable. The possibility exists that one or more signaling or second-messenger pathways interact to result in the acrosome reaction, and subsequent penetration of the oocyte vestments by the spermatozoon.25, 35, 36 The spermatozoon may have sensitive control mechanisms for regulating cellular responses as it swims through the varied environment of the female reproductive tract. In fact, this arrangement could provide sperm with the ability to sense and respond to molecules present in the female reproductive tract that have been shown to initiate the acrosome reaction, such as follicular and oviductal fluids and cumulus oophorus.

After a spermatozoon is able to pass through the zona, it must contact, bind to, and fuse with the oocyte plasma membrane. As a result of the prior acrosome reaction, new sperm membrane proteins become exposed that are likely to prove integral for sperm-oocyte fusion.

Data indicate that sperm-oocyte fusion is initiated by signal transduction processes that involve adhesion molecules on both sperm and oocyte plasma membranes. These molecules are beginning to be characterized and they belong to the family of integrins.37, 38, 39 Integrins are a class of heterodimeric adhesion receptor molecules that participate in cell-to-cell and cell-to-substratum interactions, and they are present on essentially all human cells. Integrins that recognize the Arg-Gly-Asp sequence (RGD) have been detected on the plasma membrane of oocytes. Fibronectin and vitronectin are glycoproteins that contain functional RGD sequences, and they are present on spermatozoa.37, 38, 39, 40 When oligopeptides specifically designed to block fibronectin or vitronectin receptors were tested on human spermatozoa in a zona-free hamster oocyte assay, it was found that the peptide for blocking cell attachment to fibronectin was without effect but the other peptide, which blocks both fibronectin and vitronectin receptors, inhibited sperm-oocyte binding. These data suggest that a possible mechanism for sperm-oocyte adhesion and fusion involves an integrin-vitronectin receptor-ligand interaction.41

Another potential ligand for oolemmal integrin is human fertilin.42, 43 Fertilin, formerly PH30, is a heterodimeric sperm surface protein with binding and fusion domains compatible for interaction with integrin receptors on the oocyte. Because of its domains, human fertilin β can be identified as a member of the ADAM family (membrane-anchored proteins having A Disintegrin And Metalloprotease domain).42, 43 The possibility exists that fertilin and vitronectin act together or in a parallel fashion during gamete interaction.

At some point during or after the fusion process, the oocyte is induced by the spermatozoon to become activated.44 Activation involves the resumption of meiosis through inactivation of metaphase promoting factor (MPF) which functions to arrest the oocyte in metaphase of the second meiotic division. Extrusion of the second polar body occurs and cortical granules are released into the perivitelline space. The cortical granules modify zona glycoproteins 2 and 3 on the inner aspect of the zona pellucida, resulting in a loss of their ability to stimulate the acrosome reaction and tight binding, so as to prevent polyspermy. This latter event occurs before or simultaneously with the resumption of meiosis. Failure of the oocyte to synthesize or release the cortical granules in a timely fashion results in polyspermic fertilization.

The first event after incorporation of the spermatozoon into the oocyte is the production of sperm-induced calcium (Ca2+) transients. Calcium is the main intracellular signal responsible for the initiation of oocyte activation. These calcium fluxes occur in series and over time (termed “calcium oscillations”); when only a single transient is induced, either by chemical or mechanical stimulation, the oocyte fails to activate. The mechanism by which sperm induce calcium transients is unknown, but there are data that support essentially two models for sperm-induced oocyte activation.44, 45

One proposed mechanism for sperm-induced oocyte activation is the binding of the spermatozoon to a receptor on the oolemma, which results in G-protein activation, activation of an amplifying enzyme, and generation of an intracellular second messenger within the oocyte.

A second possible mechanism for sperm-induced oocyte activation can loosely be termed the “fusion hypothesis”.44 In this model, at the time of sperm and oocyte membrane fusion a “latent” period ensues. During this latent period, a soluble sperm-derived factor diffuses from the sperm into the oocyte's cytoplasm and results in oocyte activation.46, 47, 48, 49, 50 To date, however, there are no published reports demonstrating that the extract from a single spermatozoon was able to activate an oocyte.

Abnormalities in transcription, translation, or any other significant molecular process responsible for producing the oocyte-activating ligand/effector molecule during spermatogenesis or spermiogenesis will ultimately render the fertilization event moot.

As the sperm nucleus is undergoing oocyte mediated decondensation, the sperm centrosome is orchestrating pronuclear mobilization, syngamy, and, ultimately, early cleavage. The sperm centrosome, with the assistance of maternal γ-tubulin, nucleates sperm astral microtubules and forms the mitotic spindle. The sperm aster, the name for the radial array of these microtubules, unites paternal and maternal pronuclei. At the time of fertilization, the sperm introduces the centrosome, which is the organizing center for microtubules. In doing so, it establishes the polarity and three-dimensional structure of the embryo.48, 51 In humans, defects in microtubule organization are one cause of fertilization failures seen in IVF and may explain fertilization failures that occur after intracytoplasmic sperm injection (ICSI).52


As mentioned previously, fertilization occurs in the ampulla. Transit time of the zygote from the ampulla to the ampulla-isthmic junction is approximately 30 hours, after which the zygote remains in the isthmus another 30 hours before resuming transit through the isthmus. It is not until the 5th or 6th day after fertilization that the preimplantation embryo arrives into the uterine cavity. During the time frame from fertilization to deposition of the embryo in the uterus, the propulsive forces in the fallopian tube are towards the uterus.2

The fallopian tube and its microenvironment are ideal for early embryo development. Indeed, when human embryos are cocultured on human fallopian tube epithelial cells, higher implantation and lower spontaneous abortion rates are achieved.53 Therefore, it would appear that complex interactions take place between the oviductal epithelium and the embryo. Human oviductal cells are known to secrete growth factors, cytokines, and other embryotropic factors (ETFs) that enhance and support the development of the preimplantation embryos.54, 55 Oviductal cells may also affect gene expression of the preimplantation embryo.56, 57 Much more knowledge is necessary before we can understand the contributions of the tubal environment to embryo development. However, synchrony between uterine endometrium and embryo development must be in place for successful implantation to be achieved.


In the last few years the understanding of human oocyte transport and fertilization has greatly improved; however, there are still molecular aspects of the process that need further characterization. The ARTs have provided us with numerous tools to better understand this complex process. Yet, the in vitro environment will never completely replicate the in vivo one. Perhaps new and improved tissue culture conditions will facilitate advances in elucidating the complexities of sperm-oocyte interaction. Much activity is now being directed toward the refinement of fallopian tube cell culture in an effort to better understand fallopian tube physiology, function, and sperm-epithelial cell interaction. Many fascinating results are being reported from these pioneering investigations.54, 58, 59, 60

In conclusion, a wealth of information has been obtained in the last decade concerning the processes of human fertilization and implantation. A further expansion of this knowledge will take place rapidly over the next decade as more accurate invasive and noninvasive microprobes are evolved for revealing the subtle and complex nature of ovulation, oocyte transport, gamete interaction, and early embryonic development.



Eddy CA, Pauerstein CJ: Anatomy and physiology of the fallopian tube. Clin Obstet Gynecol 23: 1177, 1980



Pulkkinen MO: Oviductal function is critical for very early human life. Ann Med 27: 307, 1995



Wildt L, Kissler S, Licht P, et al: Sperm transport in the human female genital tract and its modulation by oxytocin as assessed by hysterosalpingoscintigraphy, hysterotonography, electrohysterography and Doppler sonography. Hum Reprod Update 4: 655, 1998



Sharma V, Pampiglione JS, Mason BA, Campbell S, Riddle A. Experience with peritoneal oocyte and sperm transfer as an outpatient-based treatment for infertility. Fertil Steril. Mar 1991;55(3):579-582.



El Kady AA SG, Lawrence KA, et al. The tubal hood: A potentially reversible sterilization technique. . Hagerstown, MD: Harper & Row; 1978.



Settlage DS, Motoshima M, Tredway DR. Sperm transport from the external cervical os to the fallopian tubes in women: a time and quantitation study. Fertil Steril. Sep 1973;24(9):655-661.



De Jonge C: Attributes of the fertile spermatozoa: An update. J Androl 20: 463, 1999



Yanagimachi R: Mammalian fertilization. In Knobil E, Neill J (eds): The Physiology of Reproduction, p 189. Vol 1. New York: Raven Press, 1994



Chang MC. Fertilizing capacity of spermatozoa deposited into the fallopian tubes. Nature. Oct 20 1951;168(4277):697-698.Yanagimachi R: Mammalian fertilization. In Knobil E, Neill J (eds): The Physiology of Reproduction, p 189. Vol 1. New York: Raven Press, 1994



Austin CR. The capacitation of the mammalian sperm. Nature. Aug 23 1952;170(4321):326.



Carrera A, Moos J, Ning XP, et al. Regulation of protein tyrosine phosphorylation in human sperm by a calcium/calmodulin-dependent mechanism: identification of A kinase anchor proteins as major substrates for tyrosine phosphorylation. Dev Biol. Nov 25 1996;180(1):284-296.



de Lamirande E, Leclerc P, Gagnon C. Capacitation as a regulatory event that primes spermatozoa for the acrosome reaction and fertilization. Mol Hum Reprod. Mar 1997;3(3):175-194.



Hamamah S , Gadella BM, et Lipid composition of sperm plasma membrane: Alteration during the fertilization process. Paris: INSERM; 1996.



Benoff S. Carbohydrates and fertilization: an overview. Mol Hum Reprod. Jul 1997;3(7):599-637.



Kopf GS , Moos J, et al. Integration of tyrosine kinase- and G-protein-mediated signal transduction pathways in the regulation of mammalian sperm function. . Paris: John Libbey Eurotext, Ltd., Colloque INSERM; 1995.



Eddy EM. The spermatozoon. . New York: Raven Press; 1994.



Zaneveld LJD. Mammalian sperm acrosomal enzymes and the acrosome reaction. New York: Plenum Press; 1991.



Blackmore PF, Beebe SJ, Danforth DR, Alexander N. Progesterone and 17 alpha-hydroxyprogesterone. Novel stimulators of calcium influx in human sperm. J Biol Chem. Jan 25 1990;265(3):1376-1380.



Thomas P, Meizel S. An influx of extracellular calcium is required for initiation of the human sperm acrosome reaction induced by human follicular fluid. Gamete Res. Aug 1988;20(4):397-411.



Thomas P, Meizel S. Phosphatidylinositol 4,5-bisphosphate hydrolysis in human sperm stimulated with follicular fluid or progesterone is dependent upon Ca2+ influx. Biochem J. Dec 1 1989;264(2):539-546.



Tesarik J, Carreras A, Mendoza C. Single cell analysis of tyrosine kinase dependent and independent Ca2+ fluxes in progesterone induced acrosome reaction. Mol Hum Reprod. Apr 1996;2(4):225-232.



Baldi E, Casano R, Falsetti C, Krausz C, Maggi M, Forti G. Intracellular calcium accumulation and responsiveness to progesterone in capacitating human spermatozoa. J Androl. Sep-Oct 1991;12(5):323-330.



Anderson RA, Feathergill KA, Drisdel RC, Rawlins RG, Mack SR, Zaneveld LJ. Atrial natriuretic peptide (ANP) as a stimulus of the human acrosome reaction and a component of ovarian follicular fluid: correlation of follicular ANP content with in vitro fertilization outcome. J Androl. Jan-Feb 1994;15(1):61-70.



Liu DY, Baker HW. Acrosome status and morphology of human spermatozoa bound to the zona pellucida and oolemma determined using oocytes that failed to fertilize in vitro. Hum Reprod. Apr 1994;9(4):673-679.



Bielfeld P, Faridi A, Zaneveld LJ, De Jonge CJ. The zona pellucida-induced acrosome reaction of human spermatozoa is mediated by protein kinases. Fertil Steril. Mar 1994;61(3):536-541.



Bleil J. Sperm receptors of mammalian eggs. Vol 1. Boca Raton, FL: CRC Press; 1991.



Cross NL, Morales P, Overstreet JW, Hanson FW. Induction of acrosome reactions by the human zona pellucida. Biol Reprod. Feb 1988;38(1):235-244.



Barratt CH, DP. Induction of the human acrosome reaction by rhuZP3. Paris: John Libbey Eurotext, Ltd, Colloque INSERM; 1995.



van Duin M, Polman JE, De Breet IT, et al. Recombinant human zona pellucida protein ZP3 produced by chinese hamster ovary cells induces the human sperm acrosome reaction and promotes sperm-egg fusion. Biol Reprod. Oct 1994;51(4):607-617.



Chakravarty S, Kadunganattil S, Bansal P, Sharma RK, Gupta SK. Relevance of glycosylation of human zona pellucida glycoproteins for their binding to capacitated human spermatozoa and subsequent induction of acrosomal exocytosis. Mol Reprod Dev. Jan 2008;75(1):75-88.



Chakravarty S, Suraj K, Gupta SK. Baculovirus-expressed recombinant human zona pellucida glycoprotein-B induces acrosomal exocytosis in capacitated spermatozoa in addition to zona pellucida glycoprotein-C. Mol Hum Reprod. May 2005;11(5):365-372.



Chiu PC, Wong BS, Chung MK, et al. Effects of native human zona pellucida glycoproteins 3 and 4 on acrosome reaction and zona pellucida binding of human spermatozoa. Biol Reprod. Nov 2008;79(5):869-877.



Burks DJ, Carballada R, Moore HD, Saling PM. Interaction of a tyrosine kinase from human sperm with the zona pellucida at fertilization. Science. Jul 7 1995;269(5220):83-86.



Tesarik J, Moos J, Mendoza C. Stimulation of protein tyrosine phosphorylation by a progesterone receptor on the cell surface of human sperm. Endocrinology. Jul 1993;133(1):328-335.



Zaneveld LJ, De Jonge CJ, Anderson RA, Mack SR. Human sperm capacitation and the acrosome reaction. Hum Reprod. Oct 1991;6(9):1265-1274.



Doherty CM, Tarchala SM, Radwanska E, De Jonge CJ. Characterization of two second messenger pathways and their interactions in eliciting the human sperm acrosome reaction. J Androl. Jan-Feb 1995;16(1):36-46.



Allen CA, Green DP. The mammalian acrosome reaction: gate



Bronson RA, Fusi FM. Integrins and human reproduction. Mol Hum Reprod. Mar 1996;2(3):153-168.



Snell WJ, White JM. The molecules of mammalian fertilization. Cell. May 31 1996;85(5):629-637.



Fusi FM, Vignali M, Gailit J, Bronson RA. Mammalian oocytes exhibit specific recognition of the RGD (Arg-Gly-Asp) tripeptide and express oolemmal integrins. Mol Reprod Dev. Oct 1993;36(2):212-219.



Fusi FM, Bernocchi N, Ferrari A, Bronson RA. Is vitronectin the velcro that binds the gametes together? Mol Hum Reprod. Nov 1996;2(11):859-866.



Evans JP. Sperm disintegrins, egg integrins, and other cell adhesion molecules of mammalian gamete plasma membrane interactions. Front Biosci. Jan 15 1999;4:D114-131.



Vidaeus CM, von Kapp-Herr C, Golden WL, Eddy RL, Shows TB, Herr JC. Human fertilin beta: identification, characterization, and chromosomal mapping of an ADAM gene family member. Mol Reprod Dev. Mar 1997;46(3):363-369.



Schultz RM, Kopf GS. Molecular basis of mammalian egg activation. Curr Top Dev Biol. 1995;30:21-62.



Wilding M, Dale B. Sperm factor: what is it and what does it do? Mol Hum Reprod. Mar 1997;3(3):269-273.



Dale B, Fortunato A, Monfrecola V, Tosti E. A soluble sperm factor gates Ca(2+)-activated K+ channels in human oocytes. J Assist Reprod Genet. Aug 1996;13(7):573-577.



Parrington J, Swann K, Shevchenko VI, Sesay AK, Lai FA. Calcium oscillations in mammalian eggs triggered by a soluble sperm protein. Nature. Jan 25 1996;379(6563):364-368.



Schatten G. The centrosome and its mode of inheritance: the reduction of the centrosome during gametogenesis and its restoration during fertilization. Dev Biol. Oct 1994;165(2):299-335.



Stice SL, Robl JM. Activation of mammalian oocytes by a factor obtained from rabbit sperm. Mol Reprod Dev. Mar 1990;25(3):272-280.



Swann K. A cytosolic sperm factor stimulates repetitive calcium increases and mimics fertilization in hamster eggs. Development. Dec 1990;110(4):1295-1302.



Hewitson LS, Takahashi C et al The role of the sperm centrosome during human fertilization and embryonic development: Implications for intracytoplasmic sperm injection and other sophisticated ART strategies. . Lancaster, UK: Parthenon Publishing; 1998.



Simerly C, Wu GJ, Zoran S, et al. The paternal inheritance of the centrosome, the cell's microtubule-organizing center, in humans, and the implications for infertility. Nat Med. Jan 1995;1(1):47-52.



Xu JS, Cheung TM, Chan ST, Ho PC, Yeung WS. Temporal effect of human oviductal cell and its derived embryotrophic factors on mouse embryo development. Biol Reprod. Nov 2001;65(5):1481-1488.



Menezo Y, Guerin P. The mammalian oviduct: biochemistry and physiology. Eur J Obstet Gynecol Reprod Biol. May 1997;73(1):99-104.



Watson AJ, Westhusin ME, Winger QA. IGF paracrine and autocrine interactions between conceptus and oviduct. J Reprod Fertil Suppl. 1999;54:303-315.



Lee KF, Chow JF, Xu JS, Chan ST, Ip SM, Yeung WS. A comparative study of gene expression in murine embryos developed in vivo, cultured in vitro, and cocultured with human oviductal cells using messenger ribonucleic acid differential display. Biol Reprod. Mar 2001;64(3):910-917.



Lonergan P, Rizos D, Kanka J, et al. Temporal sensitivity of bovine embryos to culture environment after fertilization and the implications for blastocyst quality. Reproduction. Sep 2003;126(3):337-346.



Downing SJ, Maguiness SD, Watson A, Leese HJ. Electrophysiological basis of human fallopian tubal fluid formation. J Reprod Fertil. Sep 1997;111(1):29-34.



Pacey AA, Hill CJ, Scudamore IW, Warren MA, Barratt CL, Cooke ID. The interaction in vitro of human spermatozoa with epithelial cells from the human uterine (fallopian) tube. Hum Reprod. Feb 1995;10(2):360-366.



Yeung WS, Lau EY, Chan ST, Ho PC. Coculture with homologous oviductal cells improved the implantation of human embryos--a prospective randomized control trial. J Assist Reprod Genet. Nov 1996;13(10):762-767.

Back to Top